CFI-400945
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for CFI-400945, covering 2024-08-09 to 2026-01-30. Get the full timeline:
Most recent: Clinical Trial Update: CFI-400945 in Patients With Advanced/Metastatic Breast Cancer [Phase 2]